ArticleCancer cell2018

Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.

Antoine Forget et al.PubMed ↗Publisher ↗

No numbers read from the abstract.